Advertisement
Screener

BIOCERES CROP SOLUTIONS CORP. (BIOX) Cash Flows From Used In Investing Activities

1.7 / 5 stars · 11/33 Roast Me

BIOCERES CROP SOLUTIONS CORP. Cash Flows From Used In Investing Activities

BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Cash Flows From Used In Investing Activities of -$4.07 million for the 6-month period ending 2025-12-31, per its 6-K filed 2026-03-13.

Financial Statements › Cash Flow › Investing Activities

ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-03-13

  • BIOCERES CROP SOLUTIONS CORP. cash flows from used in investing activities for the quarter ending 2025-12-31 was -$2.80M.
  • BIOCERES CROP SOLUTIONS CORP. cash flows from used in investing activities for the quarter ending 2025-09-30 was -$1.26M, a 565.14% decline year-over-year.
  • BIOCERES CROP SOLUTIONS CORP. cash flows from used in investing activities for the quarter ending 2025-06-30 was $1.49M.
  • BIOCERES CROP SOLUTIONS CORP. cash flows from used in investing activities for the quarter ending 2025-03-31 was -$2.50M.
Period endCash Flows From Used In Investing Activities 3 monthCash Flows From Used In Investing Activities 6 monthCash Flows From Used In Investing Activities 6 month as first filedCash Flows From Used In Investing Activities 9 monthCash Flows From Used In Investing Activities 12 monthCash Flows From Used In Investing Activities 12 month as first filed
2025-12-31-$2.80M
derived: 6-K 6 month − 6-K 3 month · filed 2026-03-13
-$4.07M
6-K · filed 2026-03-13
-$2.58M
derived: sum of 3 quarters · filed 2026-03-13
-$5.08M
derived: sum of 4 quarters · filed 2026-03-13
2025-09-30-$1.26M
6-K · filed 2025-11-26
$222.24K
derived: sum of 2 quarters · filed 2025-11-26
-$2.28M
derived: sum of 3 quarters · filed 2025-11-26
-$7.66M
derived: sum of 4 quarters · filed 2026-03-13
2025-06-30$1.49M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
-$1.02M
derived: sum of 2 quarters · filed 2025-11-10
-$6.40M
derived: sum of 3 quarters · filed 2026-03-13
-$6.13M
20-F · filed 2025-11-10
2025-03-31-$2.50M
derived: 6-K 9 month − 6-K 6 month · filed 2025-06-20
-$7.89M
derived: sum of 2 quarters · filed 2026-03-13
-$7.62M
6-K · filed 2025-06-20
-$7.91M
derived: sum of 4 quarters · filed 2026-03-13
2024-12-31-$5.39M
derived: 6-K 6 month − 6-K 3 month · filed 2026-03-13
-$5.11M
6-K · filed 2026-03-13
-$5.41M
derived: sum of 3 quarters · filed 2026-03-13
-$6.78M
derived: sum of 4 quarters · filed 2026-03-13
2024-09-30$271.76K
6-K · filed 2025-11-26
-$23.30K
derived: sum of 2 quarters · filed 2025-11-26
-$1.39M
derived: sum of 3 quarters · filed 2025-11-26
-$19.77M
derived: sum of 4 quarters · filed 2025-11-26
2024-06-30-$295.06K
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
-$1.67M
derived: sum of 2 quarters · filed 2025-11-10
-$20.04M
derived: sum of 3 quarters · filed 2025-11-10
-$28.73M
20-F · filed 2025-11-10
2024-03-31-$1.37M
derived: 6-K 9 month − 6-K 6 month · filed 2025-06-20
-$19.75M
derived: sum of 2 quarters · filed 2025-06-20
-$28.43M
6-K · filed 2025-06-20
-$31.68M
derived: sum of 4 quarters · filed 2025-11-10
2023-12-31-$18.38M
derived: 6-K 6 month − 6-K 3 month · filed 2025-02-28
-$27.06M
6-K · filed 2025-02-28
-$30.30M
derived: sum of 3 quarters · filed 2025-11-10
-$33.57M
derived: sum of 4 quarters · filed 2025-11-10
2023-09-30-$8.69M
6-K · filed 2024-11-27
-$11.93M
derived: sum of 2 quarters · filed 2025-11-10
-$15.19M
derived: sum of 3 quarters · filed 2025-11-10
-$37.44M
derived: sum of 4 quarters · filed 2025-11-10
2023-06-30-$3.24M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
-$6.51M
derived: sum of 2 quarters · filed 2025-11-10
-$28.75M
derived: sum of 3 quarters · filed 2025-11-10
-$25.73M
20-F · filed 2025-11-10
2023-03-31-$3.26M
derived: 6-K 9 month − 6-K 6 month · filed 2024-05-29
-$25.51M
derived: sum of 2 quarters · filed 2024-05-29
-$22.48M
6-K · filed 2024-05-29
-$23.87M
derived: sum of 4 quarters · filed 2024-10-30
2022-12-31-$22.25M
derived: 6-K 6 month − 6-K 3 month · filed 2024-02-28
-$19.22M
6-K · filed 2024-02-28
-$20.60M
derived: sum of 3 quarters · filed 2024-10-30
-$20.28M
derived: sum of 4 quarters · filed 2024-10-30
2022-09-30$3.03M
6-K · filed 2023-11-29
$1.64M
derived: sum of 2 quarters · filed 2024-10-30
$1.96M
derived: sum of 3 quarters · filed 2024-10-30
2022-06-30-$1.38M
derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30
-$1.06M
derived: sum of 2 quarters · filed 2024-10-30
$2.90M
20-F · filed 2024-10-30
2022-03-31$318.56K
derived: 6-K 9 month − 6-K 6 month · filed 2023-05-24
$4.29M
6-K · filed 2023-05-24
2021-12-31$3.97M
6-K · filed 2023-02-28
2021-06-30-$8.31M
20-F · filed 2023-11-14
2020-12-31-$12.20M
6-K · filed 2022-02-25
$1.56M
6-K · filed 2021-02-26
2020-06-30-$7.80M
20-F · filed 2022-10-28
-$22.21M
20-F · filed 2020-10-21
2019-12-31-$1.59M
6-K · filed 2021-02-26
2019-06-30-$3.26M
20-F · filed 2021-10-29
2018-12-31-$1.55M
6-K/A · filed 2020-03-17
2018-06-30-$8.22M
20-F · filed 2020-10-21
2017-06-30-$10.08M
20-F · filed 2019-10-24
2016-12-31-$41.87M
20-F · filed 2019-10-24